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INTRODUCTION
Adult  renal  tumors  comprise  of  neoplasms  originating  from  renal 
tubular epithelium, urothelium of pelvis, mesenchymal tumors and mixed type 
of tumors. Among these, renal cell carcinomas (RCC) form the largest group. 
Over the recent years, there has been approximately 3% annual increase world 
wide1 in the age adjusted incidence of renal cell carcinoma. RCC is actually a 
group  of  cancers,  each  with  a  common  cellular  origin,  distinct  genetic 
abnormalities and unique morphological features.
A number of risk factors – cigarette smoking elevated Body Mass Index, 
hypertension,  having  a  first  degree  relative  with  kidney  cancer,  End  stage 
Renal Disease2  have been identified RCC is known to occur sporadically as 
well as part of inherited cancer syndromes like Von Hippel Lindau Syndrome, 
Hereditary papillary RCC,  Birt Hogg Dube syndrome, Hereditary leiomyoma 
RCC3.
The clinical presentation and management of RCC are changing very 
rapidly, driven by advances in medical imaging, genetics, molecular pathology, 
surgery, immunotherapy and targeted therapy.
The clinical outcomes of the various histological subtypes are different 
and  accurate  histological  classification  needs  attention  to  gross  features, 
architectural and cytological characteristics with support from histochemical, 
immunohistological and cytogenetic studies.
Transitional  cell  carcinoma  (TCC)  of  renal  pelvis  contributes  to  a 
significant proportion of adult renal neoplasms. They are essentially similar to 
TCC arising in the ureter / urinary bladder.
Oncocyloma  and  Papillary  adenoma  are  benign  renal  epithelial 
neoplasms that have to be differentiated from renal cell carcinoma and can be 
cured by nephrectomy alone.
Angiomyolipoma is the most common mesenchymal tumor of kidney 
and  was  previously  considered  to  be  a  hamartoma.  It  has  recently  been 
proposed  that  the  periepitheloid  cell4 is  the  cell  of  origin.  Although  the 
diagnosis of angiomyolipoma is usually straight forward, some cases may show 
unusual  morphological  features  that  may  sometimes  lead  to  erroneous 
diagnosis of malignancy.
AIMS OF THIS STUDY
1. To record  the  frequency of  adult  renal  neoplasms,  particularly  RCC 
among surgical pathology specimens at our Institution. 
2. To  study  the  pathological  characteristics  of  these  neoplasms  and 
subtype them according to established classification systems.
3. To  evaluate  the  conventional  morphological  prognostic  parameters 
among the various histological subtypes.
4. To compare the histomorphological profile of these cases with those 
reported in literature.
REVIEW OF LITERATURE
Renal neoplasms found their way into medical records as early as 1826 
with  Konig’s  accurate  gross  description  of  kidney  tumors5 and  histological 
studies by Robin (1855) and Waldeyer (1867). They were presumed to arise 
from proliferation of renal tubular epithelium which later invade the membrana 
propia and result in a nodular growth.
Grawitz observed the gross and microscopic resemblance of the tumor 
with adrenal tissue and suggested an origin from adrenal rests within the kidney 
and coined the term, ‘struma lipomatodes aberrata renis’.
In the late 19th century, Doderlein and Birsch Hirschfeld conceived the 
term hypernephroma. Oberling et al5 laid to rest the controversy regarding the 
origin of RCC by providing conclusive electron microscopic (EM) evidence of 
its origin from renal tubular epithelium. However, recent immunohistochemical 
findings suggest that they may develop from proximal convoluted tubule (PCT) 
and collecting duct (CD).
EPIDEMIOLOGY :
The  incidence  of  kidney  cancer  is  considerably  higher  in  developed 
countries than in developing countries. It affects 1 – 3% of all cancer patients. 
According  to  the  world  cancer  report6,  189000  new  cancers  are  being 
diagnosed worldwide each year.
The  sex  ratio  is  1.6  to  2:1  in  favour  of  men  and  most  cases  occur 
between 50 and 70 years of age. Kidney cancer causes the death of more than 
91000 people each year.
Although the incidence is lesser in Indians when compared to western 
society, it appears to be steadily increasing. According to the Population Based 
Cancer  Registry7 maintained  at  Cancer  Institute  (WIA),  Chennai,  the 
proportion  of kidney cancer  among all  malignancies  during 1984 – 93 was 
0.66% in males and 0.23% for females. The same figures rose to 1.22% for 
males and 0.53% for females during 1999 – 2000.
ETIOLOGY :
Numerous agents are known to be associated with development of renal 
cell  carcinoma.  (McLaughlin  and  Lipworth,  2000).  The  association  with 
smoking was first  established as causative for TCC of bladder and has now 
been extended to RCC2. An increased risk of RCC has been liked to obesity 
and diuretic  therapy,  particularly  in  women.  The influence of  beverages,  in 
particular  coffee and alcohol has  not  been clearly  determined despite  many 
studies.
Patients  with  kidney  damage  secondary  to  phenacetin  containing 
analgesic abuse, have an increased risk of TCC. VHL, an autosomal dominant 
condition  is  a  predisposing  factor.  Long  term  hemodialysis  used  in  the 
treatment of chronic renal disease leads to an increased incidence of acquired 
cystic disease, which in turn leads to increased risk of RCC.
ETIOLOGICAL FACTORS :
RCC :
 Cigarette smoking
 Germline mutations 
 Obesity (in women)
 Hemodialysis (long term)
 Hypertension 
 Sickle cell trait.
UROTHELIAL CARCINOMA OF RENAL PELVIS
 Cigarette smoking
 Phenacetin abuse 
 Thorium exposure
 Balkan nephropathy
 Urothelial tumor of urinary bladder
EVOLUTION OF CLASSIFICATION AND STAGING SYSTEMS
The earliest known classification system was devised by Konig based on 
gross morphology – fungoid, medullary, scirrhous, steatomatous types.
According to microscopic appearance, RCC was initially grouped into four 
main  histological  types  –  clear  cell,  granular  cell,  tubulopapillary  and 
sarcomatoid. Later as a result of greater sophistication in tumor analyses 
(histochemistry,  EM  of  microvesides,  1HC  of  mtermediate  filaments), 
many  other  distinct  types  were  suggested  which  resulted  in  the  Mainz 
classification.
This  system  recognised  clear  cell,  chromophobe,  chromophil,  spindle 
shaped, oncocytic and unclassified types.
In the 1990s, advances in the understanding of genetic alterations in RCC 
reinforced the concept that there were distinct subtypes of RCC, each with 
its own genetic lesions. Different genetic alterations affect cellular biology 
differently, leading to different tumor morphology and behaviour.
The  Heidelberg  classification8 (1996)  sought  to  integrate  these  genetic 
lesions  with  readily  recognizable  histological  types  –  conventional, 
papillary, chromophobe, collecting duct and unclassified types (Kovacs et 
al 1997).
In  1997,  UICC  and  AJCC9 released  their  combined  workgroup 
classification  of  RCC.  This  was  based  on  Mainz  classification  but  like 
Heidelberg workshop, took into consideration and integrated morphology 
with genetic features.
UICC/ AJCC (Storkel et al, 1997)
BENIGN :
Papillary adenoma
Renal oncocytoma
Metanephric adenoma
Metarephic adenofibroma
MALIGNANT :
Conventional (clear) cell RCC
Papillary RCC
Chromophobe RCC
Collecting duct carcinoma
Unclassified RCC
CLASSIFICATION OF RENAL TUMORS IN ADULTS (WHO 2004)
RENAL EPITHELIAL TUMORS 
BENIGN
Renal oncocytoma
Papillary adenoma
Metanephric adenoma
Metanephric adenofibroma
MALIGNANT
Clear cell (conventional) RCC
Papillary RCC
Chromophobe RCC
Collecting duct carcinoma 
Medullary carcinoma  
Mucunous tubular and spindle cell 
carcinoma 
XpII translocation carcinoma
Renal cell carcinoma, unclassified
TUMORS OF UNDETERMINED MALIGNANT POTENTIAL
Multilocular cystic RCC
MIXED EPITHELIAL AND STROMAL TUMORS 
Mixed epithelial and stromal tumor
Cystic nephroma
NON EPITHELIAL TUMOURS 
BENIGN
Renomedullary interstitial cell 
tumor 
Angiomyolipoma
Juxta glomerular cell tumor
Metanephric stromal tumor
Solitary fibrous tumor
Lipoma 
Leiomyoma
Hemangioma 
Lymphangioma
MALIGNANT
Leiomyosarcoma 
Rhabdomyosarcoma 
Synovial sarcoma 
Liposarcoma 
MISCELLANEOUS TUMORS
Carcinoid tumor
PNET
Small cell carcinoma
Metastatic tumors
Hematopoietic tumors
Unclassified RCC remains as a diagnostic category for tumors that do not 
adequately fulfill the criteria for all other categories.
Sarcomatoid and granular categories have been removed from current RCC 
tumor classification schemes because these terms are no longer considered 
useful. Sarcomatoid RCC is not a distinct histological entity and represents 
high grade transformation in different  subtypes of RCC10.  Granular  cells 
have been found in almost all subtypes in varying proportions.
A variant  of  clear  cell  RCC with predominantly  cystic  pattern called as 
multilocular cystic RCC is thought to have low potential for recurrence or 
metastasis. Papillary RCC is divided into type I and type II based on the 
cells lining the papillae.
Chromophobe RCC has been proposed to originate in the intercalated cells 
of the renal collecting ducts and there is a high proportion of low stage 
tumors at presentation.
Collecting duct carcinoma or Bellini duct carcinoma, an aggressive RCC 
variant, appearing to arise in medullary collecting ducts. Renal medullary 
carcinoma is a newly described variant of the collecting duct type which 
occurs almost exclusively in African – American men with sickle cell trait 
or sickle cell disease.
Cell of Origin of Renal tumors11
Cells of Proximal 
Convoluted tubule Clear cell RCC
Cells of Distal 
Convoluted tubule Papillary RCC
Proximal nephron
RCC is now recognised as a family of cancers  that  results  from distinct 
genetic  abnormalities with unique morphological features but all  derived 
from renal tubular epithelium. Conditions that may be complicated by RCC 
are VHL, acquired cystic disease, adult form of polycystic kidney disease, 
Tuberous  Sclerosis,  Neuroblastoma,  familial  cutaneous  leiomyomatosis, 
malignant lymphoma.
The tumor is usually centred at the cortex, grows asymmetrically, extending 
towards the renal capsule and also towards the pelvis. The renal sinus is the 
compartment of fatty tissue located within the confines of the kidney that 
envelopes the collecting system. The absence of a fibrous barrier between 
the  renal  sinus  and  the  renal  cortex  enables  easy  access  to  vascular 
structures in the sinus. In this way, the tumor may invade the renal vein, 
Tubular and spindle 
cell tumour 
Oncocytoma 
Chromophobe RCC
Collecting duct carcinoma 
Medullary carcinoma
Loop of Henle
or collecting  ducts
Intercalated cells of 
renal cortex
Collecting ducts of renal 
medulla
Distal nephron 
inferior vena cava and can even extend into the right atrium. Renal sinus 
invasion  is  the  most  common  site  of  extra  renal  extension  of  renal 
carcinoma.
Approximately  one  –  third  of  patients  with  RCC  already  have  distant 
metastasis12 at  the  time of  presentation.  Common sites  of  metastasis  are 
lungs and bones, mainly pelvis and femur. RCC can metastasize to unusual 
sites with a silent primary and hence can be confused with primary tumor in 
the organs in which they lodge.
The light microscopic features for subtyping RCC are fairly well defined by 
the WHO. The ultrastructural feature studied by electron microscopy lends 
additional  support  to  the  current  classification  schemes  and  provides 
insights  into possible  histiogenesis  of  renal  epithelial  neoplasms13.  Clear 
cell  RCC  showed  long  microvilli  with  abundant  cytoplasmic  lipid  and 
glycogen.  Papillary  RCC  showed  variably  sized  microvilli  and  small 
amount of cytoplasmic lipid and glycogen. Papillary RCC showed variably 
sized microvilli  and small  amount of cytoplasmic lipid but no glycogen. 
Chromophobe  RCC  showed  many  cytoplasmic  vesicles  and  abnormal 
mitochondria  with  rare  short  and  stubby  microvilli.  Renal  oncocytoma 
showed many mitochondria with few vesicles.
IMMUNOHISTOCHEMISTRY :
The diagnosis of primary or metastatic RCC can be difficult especially in 
small biopsies because of the wide variety of histological appearance and 
clinical presentation that RCC can assume. All RCCs stain positive with 
cytokeratin cocktail (AE1/AE3 and CAM 5.2), LMW CK and EMA. Clear 
cell and papillary variants also stain with vimentin whereas chromophobe 
variant  does  not  stain  with  vimentin.  Collecting  duct  carcinoma  has  a 
unique staining pattern, reacting with both low and high molecular weight 
cytokeratin,  peanut agglutinin,  Ulex europeus and EMA similar to distal 
collecting duct and tubular epithelium.
MOLECULAR GENETIC FEATURES :
Sporadic clear cell RCC typically show 3p deletion in the region harbouring 
VHL gene. Sporadic papillary RCC is characterised by trisomies especially 
of 7, 17 and loss of Y. Chromophobe RCC is characterised by combined 
losses of multiple chromosomes 1, 2, 6, 10, etc. 
GENETIC LESIONS IN RENAL TUMOURS:
Clear cell RCC          
loss of 3p
mutations/hypermethylations of VHL 
gene
Papillary RCC              
trisomies of 7 and 17
loss of chromosome Y
MET mutation in familial cases
Chromophobe RCC     hypodiploidyloss of chromosomes 1,Y,6,10,13
Renal oncocytoma       
loss of chromosome Y
t(9:12) (p23:q13)
t(5:11) (q35:q13)
Collecting duct carcinoma monosomies of 1,6,14,15,22 loss of heterozygosity of 1q
Xp11 translocation carcinoma    t(x:1) (p11.2:q21)t(x:17) (p11.2:q25)
Mucinous tubular and 
spindle cell carcinoma loss of chromosomes 1,4q,6,8p
Angiomyolipoma TSC 1 and TSC 2 gene activation
Metanephric adenoma loss of 2p
The classic diagnostic triad of clinical symptoms – hematuria, flank pain, 
abdominal mass is found only in a minority of patients. Other symptoms are 
weight  loss,  anemia,  fever  and  those  due  to  metastasis,  paraneoplastic 
syndromes  like  hypercalcemia,  leukemoid  reaction,  systemic  amylodosis 
etc.
Many pathological features were found to correlate with tumor behaviour14. 
These  include  tumor  staging,  Fuhrman’s  nuclear  grading,  histological 
subtype,  sarcomatoid  change,  amount  of  necrosis,  markers  of  tumor 
proliferation,  metastasis  etc.  However,  the  search  for  new  molecular 
prognostic markers has proved elusive over the years15.
Tumor  stage,  which  reflects  the  anatomic  spread  and  involvement  of 
disease, is recognised as the most important prognostic indicator for clinical 
behaviour  and  outcome  of  RCC.  Currently,  Robsons  staging  and  TNM 
staging systems (revised in 1997) are in use.
Robsons Staging of RCC
Stage I : Tumor confined by renal capsule 
Stage II : Tumor extension to perirenal fat or ipsilateral adrenal but 
confined by Gerota’s fascia 
Stage III 
a
: Tumor involvement of renal vein or IVC 
Stage III 
b
: Lymphatic involvement
Stage III 
c
: Veins and lymphatic involvement
Stage IV 
a
: Spread to contiguous organs except ipsilateral adrenal
Stage IV 
b
: Distant metastasis
TNM Staging of RCC
PRIMARY TUMOR (T)
T
X
Primary tumor cannot be assessed 
T
0
No evidence of primary tumor
T
1
Tumor 7cm or less in greatest dimension, limited to kidney 
T
1
a
Tumor 4cm or less in greatest dimension, limited to kidney
T
1
b
Tumor more than 4cm but less than 7cm in greatest dimension, limited to 
kidney
T
2
Tumor more than 7cm in greatest dimension, limited to kidney
T
3
Tumor extends into major veins or invades adrenal gland or perinephric 
tissue but  not beyond Geroter’s fascia
T
3
a
Tumor directly invades adrenal gland or perirenal and/ or renal sinus fat but 
not beyond Gerota’s fascia
T
3
Tumor grossly extends into the renal vein or its segmental branches or IVC 
below diaphragm
bT
3
c
Tumor grossly extends into vena cava above diaphragm or invades the wall 
of vena cava
T
4
Tumor invades beyond Gerota’s fascia
Regional Lymph Nodes (N)
N
X
Regional lymph nodes cannot be assessed 
N
0
No regional lymph node metastasis 
N
1
Metastasis in a single regional lymph node
N
2
Metastasis in more than one regional lymph node
Distant Metastasis 
M
X
Distant Metastasis cannot be 
assessed  
M
0
No distant metastasis 
M Distant Metastasis
1Numerous grading systems have been developed for RCC. Skinner16 and 
associates  in  1971 were  the  first  to  propose a  grading  system based  on 
nuclear morphology alone. Fuhrman and colleagues simplified this system 
in 1982. This method is widely in use today. Histologic tumor necrosis, if > 
50% has been shown to reflect the rate of progression of tumors17.
The recently recommended histological classification and revised TNM 
staging have allowed identification of  prognostic  groups  among patients 
with RCC.
Holger Moch and Mahul B. Amin et al18 studied the prognostic utility of 
revised TNM staging systems in 588 renal cancers. In their analysis the new 
TNM stage strongly correlated with patient survival.
Although molecular analyses have revealed genetic differences between 
morphologic  tumor  entities,  the  prognostic  significance  of  histological 
tumor  types  is  controversial.  Published  literature  shows  conflicting 
information  regarding  behaviour  of  tumor  among  different  genetic 
categories19.
Recent  reports  have  discounted  differences  in  presentation, 
morphological  features  as  well  as  patient  outcome  among  histological 
subtypes of RCC. One study found that patients with clear cell RCC were 
more likely to present with advanced stage and symptoms compared with 
patients with papillary and chromophobe RCC. In addition, 23% of patients 
with papillary RCC were multifocal  compared with only 7% and 8% of 
patients with clear cell and chromophobe RCC respectively. Cancer specific 
survival rates at 5 years following surgery for patients with chromophobe, 
papillary and clear cell RCC were 100%, 86% and 76% respectively.
Moch et  al,  in  a  similar  study  of  RCC from swiss  patients,  found  that 
patients  with  chromophobe  RCC  had  significantly  improved  prognosis 
compared with those of clear cell RCC (5 year survival rates of 78% and 
50%). They did not find significant differences in outcome between patients 
with chromophobe and papillary RCC or between patients with clear cell 
and papillary RCC.
John C. Cheville et al21, at the Mayo clinic, compared cancer specific 
survival  rates  and  examined  association  of  outcomes  with  histological 
subtypes and demonstrated significant differences, highlighting the need for 
accurate subtyping.
Mahul B. Amin, after studying 405 cases at the Henry Ford Hospital20, 
concluded that  the  clinical  outcome of  various  histological  subtypes  are 
different. These studies lent support to the morphological and the reported 
cytogenetic  –  molecular  distinctiveness  of  subtypes  of  renal  epithelial 
tumors.
Arnaud Mejean, in a review article14, has concluded that the most useful 
prognostic factors of RCC were TNM stage, histological grade, subtype, 
performance  status,  patient’s  age,  metastasis  and  time  to  appearance  of 
metastasis.  Various  other  studies  have  attempted  to  evaluate  prognostic 
factors for patient survival in different subtypes of RCC.
TCC  of  renal  pelvis  usually  occurs  in  adults.  It  may  be  seen  in 
association  with  analgesic  abuse,  thorotrast  administration  and 
cyclophosphamide  therapy.  It  usually  presents  with  hematuria  without  a 
palpable mass. Synchronous or metachronous tumors occur very commonly 
(40%). They have a tendency to implant along the ureter and hence it is 
important to resect the bladder cuff.
STAGING SYSTEM FOR TCC OF RENAL PELVIS
T
0
Non invasive papillary carcinoma
T
i
s
TCC in situ
T
1
Invasion of lamina propria
T
2
Invasion of muscularis propria
T Extension into peripelvic fat or renal parenchyma
3T
4
Invasion of adjacent organs or extension through kidney into perirenal 
fat
N
1
Metastasis in single node < 20 mm
N
2
Metastasis in single node > 20 mm and < 50 mm
Or multiple nodes each < 50 mm 
N
3
Nodal metastasis > 50 mm
M
1
Distant metastasis
Other carcinomas like squamous cell carcinoma, lymphoepithelioma 
like carcinoma, carcinosarcoma, small cell neuroendocrine carcinoma occur 
very infrequently.
Angiomyolipoma  is  a  mesenchymal  tumor  composed  of  an  intimate 
admixture of vessels, smooth muscle and fat. It can occur as a component of 
tuberous  sclerosis  complex.  Usually  the  morphology  is  characteristic  on 
hematoxylin  and  Eosin  sections  but  immunostains  may  be  needed  in 
diagnosing unusual cases. There is coexpression of muscle markers – SMA 
and muscle specific actin and markers of melaninogenesis like HMB 45. 
Hormonal  receptors  are  also  positive  in  many cases22.  Rarely  malignant 
transformation has been reported23. 
MATERIALS AND METHODS
PATIENT SELECTION :
The  surgical  specimens  and  pathology  reports  of  patients  who 
underwent radical nephrectomy for  renal  tumours during the period January 
2003  to  June  2006  at  the  Institute  of  Pathology,  Madras  Medical  College, 
formed the material for this study. Consultation slides received for institutional 
review were also included. Patients who were below 18 years of age and those 
who lacked details of important pathological features, were excluded from the 
study.
CLINICAL FEATURES :
The clinical  features such as age,  sex of the patient,  laterality of the 
tumour, and type of surgery were noted from the clinical case sheets.
GROSS MORPHOLOGY :
The gross characteristics of the tumour included the tumour location, 
size,  necrotic,  areas,  capsular  invasion,  vascular  and  ureter  invasion  were 
evaluated. These details were collected directly from the specimens or obtained 
from the pathology report registers.
The  specimens  were  fixed in  10% formalin.  After  adequate  fixation, 
gross examination was done according to protocol. Tissue bits were taken as 
were  deemed necessary  and embedded in  paraffin.  Sections  were  cut  using 
rotary microtome.  The section were stained routinely  with hematoxylin and 
Eosin. Special stains like Hale’s colloided iron were employed as and when 
required.
HALE’S DIALYSED IRON STAIN24
1. Dewax a positive control and test section and bring to distilled water
2. Treat all sections with equal parts of dialysed iron and acetic acid, 10 
min
3. Wash well in several changes of distilled water.
4. Treat with filtered Perls’ reagent, 10 min
5. Wash well in several changes of distilled water
6. Counterstain with 0.5% aqueous neutral red, 5 min
7. Wash in water
8. Rinse in absolute alcohol
9. Clear in xylene and mount in a DPX – type mountant
MICROSCOPIC FEATURES :
The microscopic features were assessed after reviewing all the available 
slides.  These  included  the  histological  subtype,  nuclear  grade,  histological 
tumour necrosis, presence of sarcomatoid component, capsular invasion, renal 
sinus invasion and ureteric invasion.
Histological  subtying  was  done  accoding  to  UICC/AJCC  and 
Heidelberg classification guidelines.
DEFINITIONS :
 The working definitions used in this study are as follows
Clear cell RCC were defined18 by a solid, acinar or cystic growth pattern 
and by predominance of cells with clear cytoplasm in routine sections, although 
large foci with eosinophilic cells were also common.
Chromophobe RCC18 had a solid, alveolar or nested architecture and an 
eosinophilic or pale cytoplasm. These tumours stained with Hale’s colloidal 
iron, showed diffuse and strong reticular positivity.
A tumour  was  considered  papillary  RCC18 if  a  papillary  architecture 
predominated  and no  solid  clear  cell  areas  were  present.  Papillary  tumours 
were divided into basophilic (type 1) and eosinophilic (type 2) according to the 
prominent cell type according to the recommendations of Delahunt, Eble and 
Amin et al. In type 1 tumours, the papillae were covered by cells with scanty 
cytoplasm, small oval nuclei with inconspicuous nucleoli, foamy macrophages 
in papillary cores and psammoma bodies. The papillae of type 2 tumours were 
covered by large cells with abundant eosinophilic cytoplasm and large nuclei 
with prominent nucleoli.
Collecting  duct  carcinoma  was  diagnosed  if  there  were  irregular 
channels lined by highly atypical epithelium and desmoplastic stroma.
Tumour  was  diagnosed  as  renal  oncocytoma  if  the  characteristic 
architectural  (nested,  tubulocystic,  mixed),  cytoplasmic  (eosinophilic  finely 
granular cytoplasm) and nuclear features (round nuclei with uniform chromatin 
distribution with or without prominent nucleoli) were present.
The term renal capsule25 was used to refer to the connective tissue layer 
that envelops the kidney along its external surface and extends slightly into the 
hilum.
Capsular invasion was defined25 as either tumour cells within vascular 
structures that are clearly within the perinephric fat or tumour cells in direct 
contact with perinephric stroma or fat cells without a connective tissue layer of 
separation.
The renal sinus25 referred to the central fatty compartment that invests 
the  collecting  system  and  abuts  the  cortical  columns  of  bertini  without  a 
connective tissue interface.
Sinus invasion25 is defined as either tumour within vascular structures 
that are clearly within the renal sinus fat or tumour cells in direct contact with 
renal sinus stroma or fat cells.
In transitional cells carcinoma the microscopic architecture was variable 
– nests, small clusters, ribbons and diffuse. The neoplastic cells were usually of 
medium size with moderate amount of cytoplasm. The degree of nuclear atypia 
was noted. Invasion into lamina propria, muscularis propria, peripelvic fat and 
renal parenchyma were looked for. The presence of necrosis, mitotic activity 
and inflammation were also recorded.
 The diagnosis of angiomyolipoma required an intimate admixture of fat, 
smooth muscle and blood vessels in varying proportions.
GRADING :
Nuclear  grade  for  clear  cell  RCC  was  determined  using  standard 
criteria16. (Fuhrman)
Grade Nucleus Nucleolus
1 Round, uniform, 10µ diameter Inconspicuous or absent 
2 Slightly irregular, 15 µ diameter Visible at x 400
3 Very irregular, 20 µ diameter Visible at x 100
4 Bizarre multilobated, 20µ diameter with 
clumped chromatin
Prominent
The highest grade occupying at least one high power field (HPF) was 
assigned to the tumour, in accordance with the criteria of Fuhrman et al.
In papillary RCC, type 1 tumours were given a nuclear grade I/II and 
type 2 tumours were given a nuclear grade III/IV.
Chromophobe RCC tumours were not given nuclear grade because of 
their uniformly indolent behaviour.
The  presence  of  a  sarcomatoid  component  in  any type  of  RCC was 
recorded.  By  definition  all  tumours  with  a  sarcomatoid  component  were 
assigned grade IV. 
Histologic  tumour  necrosis  was  defined21 as  the  presence  of  any 
microscopic coagulative necrosis. Degenerative changes such as hyalinization, 
hemorrhage and fibrosis were not considerd necrosis. The amount of necrosis 
as a percentage was quantified into 3 groups, 0-25%, 25-50% and 50-100%.
STATISTICAL ANALYSIS :
The  significance  of  differences  in  the  pathological  features  among 
different histologic subtypes were tested using Chi – square (χ2) test26.  95% 
confidence limits were set and a difference in the parameters was regarded as 
significant when P < 0.05.
DATA ANALYSIS
In our study, 79 renal tumours, were obtained during the period January 
2003 to June 2006. There were 21 cases during 2003, 25 cases during 2004, 19 
cases during 2005 and 14 cases in 2006 upto June. The proportion of renal 
cancers among all  cancers diagnosed at the department of pathology, MMC 
during the years were 0.8%, 1.4%, 1.5% and 1.17% respectively.
Frequency of Renal Cancer
0.0%
0.2%
0.4%
0.6%
0.8%
1.0%
1.2%
1.4%
1.6%
1.8%
2.0%
1 2 3 4
Out of 79 renal tumours studied, 75 (95%)  were malignant and 4 (5%) 
were  benign.  Among  the  malignant  tumours,  63  (84%)  were  RCC  and  12 
(16%) were TCC.
2003 2004 2005 2006
RENAL TUMOURS 
5%
95%
Benign
Malignant
MALIGNANT TUMOURS 
84%
16%
RCC
TCC
The various subtypes of  RCC were distributed as follows :
Table 1 :
Subtype Number Percentage
Clear cell RCC 48 76.19%
Papillary RCC 8 12.70%
Chromophobe RCC 7 11.11%
RCC SUBTYPES
76.19%
12.70%
11.11%
Clear Cell RCC
Papillary RCC
Chromophobe RCC
AGE DISTRIBUTION AND SEX RATIO
The age of patients ranged from 22 years to 80 years with a mean of 
52.61 years. The mean age for benign tumours was 42.50 years and that for 
malignancies was 53.74 years.
Table 2 :
 
Tumour
Age
Mean (yrs) Range (yrs)
Sex Ratio
(M : F)
RCC 54.03 22 – 80 2.7 : 1
TCC 53 32 – 75 5 : 1
Angiomyolipoma 41.67 22 – 55 1 : 2
Hemangioma 45 - -
The age wise distribution and sex ratio of the different subtypes of RCC 
are as follows :
Table 3:
Subtype
Age
Mean (yrs) Range (yrs)
Sex Ratio
(M : F)
Clear cell RCC 55.57 22 – 80 3.4 : 1
Chromphobe RCC 44.14 30 – 55 1.3 : 1
Papillary RCC 52.13 35 – 70 1.7 : 1
Table 4 :
Age group (yrs) RCC TCC Benign Neoplasm
20 – 30 2 0 1
30 – 40 6 3 0
40 – 50 10 1 2
50 – 60 20 2 1
60 – 70 20 5 0
70 – 80 4 1 0
80 – 90 1 0 0
Total 63 12 4
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LATERILITY :
Malignant  tumours  had a  slight  predilection for  left  kidney (1.1 :  1) 
whereas benign tumours occurred on each side with equal frequency. There 
were no bilateral tumours. Multifocality was noted in three cases of TCC.
SIZE OF TUMOUR :
The size of the tumour was taken as its greatest dimension. It ranged 
from 2 cm to 20 cm. The mean size of each histological subtype is tabulated 
below.
Table 5 :
Histological type
Size*
Mean (cm) Range (cm)
Clear cell RCC 9.2 4 – 18
Papillary RCC 8.7 5 – 15
Chromophobe RCC 12.53 9 – 20
TCC 5.9 2 – 10
Angiomyolipoma 11 8 -15
Hemangioma 7 -
*  Size was not known for 5 cases of clear cell RCC and one case of Papillary 
RCC
Mean Size of Renal Tumours
9.2
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Nuclear grading according to the Fuhrman’s criteria was done and the 
following data were obtained.
Table 6 :
Grade No. of Cases ** Percentage
I 1 2.33
II 15 34.88
III 14 32.56
IV 13 30.23
** Five cases were not assigned nuclear grades as  not all  their  slides were 
available for review.
Grading in two tier system
Table 7 :
Grade No. of cases Percentage
Low 16 37.21
High 27 62.79
The mean size of the tumours under each grade was calculated.
Table 8 :
 Grade Mean size (cm)
I 5.5
II 7.59
III 10.51
IV 10.9
Among papillary RCC, 5 cases were type I and were assigned grade I 
and 3 cases were type II and were assigned grade II.
When  Fuhrman’s  nuclear  grading  scheme  was  applied  to  7  cases  of 
chromophobe RCC, 5 were grade II and 2 cases were grade III. All 12 cases of 
TCC were grade III tumours.
Sarcomatoid components were found in 5 cases of clear cell  RCC in 
varying amounts ranging from 10 to 95%. No other subtypes showed there 
sarcomatoid changes.
NECROSIS
The  amount  of  tumour  necrosis  in  clear  cell  RCC  tumours  was 
quantified as < 25%, 25 – 50% and > 50%.
Table 9:
Necrosis No. of cases*
< 25% 19
25 – 50% 17
> 50 % 7
*  5  cases  were  excluded  because  they  did  not  have  all  the  slides  for 
quantification of necrosis.
 The amount of necrosis, analysed gradewise, is given in the following table.
Table 10:
Grade
Necrosis
< 25 % 25 – 50% > 50%
I 1 0 0
II 12 3 0
III 4 7 3
IV 2 7 4
In two tier grading system the same data can be tabulated as follows 
Table 11:
Grade
Necrosis
< 25 % 25 – 50% > 50%
Low (I/II) 13 3 0
High  (III/IV) 6 14 7
x2 = 16.10 degree of freedom (D.F) =2 P < 0.001
The correlation between age, mean size of the tumour, nuclear grade and 
necrosis was analysed.
Table 12 : 
Age group 
(yrs)
Mean size
(cm)
Nuclear 
grade
Amount of necrosis
0-30 8
II – 50%
III – 50%
< 25% - 50% cases
> 50% - 50% cases
30 – 50 8.4
II – 33%
III – 33%
IV – 33%
< 25% - 16% cases
25 – 50% - 84% cases
> 50 9.9
I – 3.2%
II – 26.8%
III – 43.4%
IV – 26.6%
< 25% - 43.2% cases
25 – 50% 33.4% cases
> 50% - 13.4 cases
CAPSULAR AND VASCULAR INVASION
The only grade I clear cell RCC did not show either capsular or vascular 
invasion. Among grade II tumours, 5 cases had capsular invasion only, 6 cases 
had vascular invasion only and 4 cases had neither.
Among  grade  III  tumours,  one  cases  had  capsular  invasion,  3  had 
vascular invasion only and 10 cases showed both.
Out of 13 grade IV tumours, 2 had capsular invasion, 3 had vascular 
invasion only and 8 cases showed both.
        Only capsular invasion Both
        Only vascular invasion Neither 
128 18
5
Table 13 :
Grade Capsular invasion only
Vascular 
invasion only Both Neither
I - - - 1 (100)
II 5 (33.33) 6 (40) - 4 (26.67)
III 1 ( 7.14) 3 (21.42) 10 (71.44) -
IV 2 (15.38) 2 (23.08) 8 (61.52) -
Total 8 12 18 5
(Figures within brackets indicate percentage of cases)
Table 14 :
Grade Capsular invasion
No capsular 
invasion Total
Rate of 
invasion
Low 5 11 16 31.25
High 21 6 27 77.78
Total 26 17 43 60.47
χ2 = 9.11 D.F. = 2 P < 0.005
Table 15 :
Grade Vascular invasion
No vascular 
invasion Total
Rate of 
invasion
Low 6 10 16 37.5%
High 24 3 27 88.89%
Total 30 13 43 69.77%
χ2 = 12.56 D.F. = 2 P < 0.001
Among 12 cases of TCC, 6 cases showed contiguous ureteric invasion.
Angiomyolipoma  was  diagnosed  in  three  cases.  The  mean  age  was 
41.67 years with sex ratio 1 : 2 in favour of females . None of the patients had 
tuberous sclerosis.
A single case of hemangioma in a 45 year F was recorded. It was 7 cm 
size. Microscopically extensive hemorrhagic areas were seen but no necrosis or 
atypical features were noted.
DISCUSSION 
The  number  of  renal  cancers  diagnosed  in  our  department  shows  a 
definite increase over the preceding three years. While increase in the number 
of surgeries is also a factor, the increase in proportion of renal cancers among 
total malignancies suggests that there is a real increase in incidence of renal 
cancer. This trend is also reflected in the statistics published7 by the Population 
Based Cancer Registry (PBCR) at Cancer Institute (WIA), Chennai.
The malignant tumours constituted the vast majority of our cases while 
benign tumours were very less in number.  (95% and 5% respectively).  The 
proportion of malignancies in our study is higher when compared to the figure 
of 86.7% in a study of 469 nephrectomies at Szeged university27.
There was a clear male preponderance in case of malignancies (2.9 : 1 ) 
which was higher for TCC (5 times) than RCC (2.7 times). This may result 
from the role of smoking as a causative factor in the pathogenesis  of renal 
cancer.
The age of patients with RCC was distributed in a wide range of 22 to 
80 years with peaks in sixth and seventh decades. TCC had a more uniform age 
distribution. Benign tumours were found in the younger age groups.
Clear cell RCC was the most frequent tumour (76.19%) in our series, 
followed by papillary RCC (12.7%) and chromophobe RCC (11.11%). These 
figures are in broad agreement with those reported by Nemeth. I et al27 (88.4%, 
5.6%, 4%) Bonsib et  al  (70.97%, 16.13%, 12.90%) and the same author in 
another study (74%, 16%, 7%).
FREQUENCY OF HISTOLOGIC SUBTYPES   
Table 16 
Histological 
subtype
Mahul 
Amin
et al20
n = 377
Holger 
Moch
et al 18
n = 588
Bonsib
et al23
n = 100
John C. 
Cheville
et al21 
n = 2385
Our study 
n = 63
Clear cell 
RCC 63% 83% 74% 83.2% 76.19%
Papillary 
RCC 18.5% 11% 16% 11.3% 12.70%
Chromophobe 
RCC 5.9% 5% 7% 4.3% 11.11%
Others 5.7% 1% 3% 1.2% -
All subtypes except papillary RCC showed a preference for left kidney 
and the male – female ratio was highest for clear cell RCC among all tumours.
The mean size of the tumour was largest for chromophobe RCC (12.53 
cm), followed by clear cell RCC (9.2 cm) and papillary RCC (8.7cm). some 
authors contend that  the  chromophobe RCC are slow growing tumours  and 
hence present with symptoms only after reaching a considerably large size.
In the study by Igor Frank et al28, the mean tumour sizes for clear cell 
RCC, papillary RCC and chromophobe RCC were 6.5cm, 4.7cm and 7.9cm 
respectively.  This  study  was  conducted  in  the  western  population  where 
patients  present  early  for  diagnosis  and  many  tumours  are  diagnosed  on 
imaging performed for other complaints.
Our study showed good correlation of size of the tumour with age. In the 
0 – 30 years age group, the mean size was 8 cm. The mean size increased to 
8.4cm for 30 – 50 yrs and 9.9cm for > 50 years age group. Presumably, the 
older age group patients present with a higher stage due to this reason.
A summary of the nuclear grading of clear cell RCC is given table 6. 
only one patient presented with grade I whereas there were fifteen patients with 
grade II, fourteen patients with grade III and thirteen patients with grade IV. 
An admixture of two or more grade was observed in 70% of our cases. The 
highest grade was assigned to the tumour in these cases.
When the grading was converted to two – tier system i.e.,  low grade 
(Fuhrman’s grade I & II) and high grade (Fuhrman’s grade III & IV) tumors, 
the  patients  were  better  segregated.  In  this  scheme,  37.21% were  classified 
under  low  grade  category  and  62.79%  were  classified  under  high  grade 
category.
The relation between Fuhrman’s nuclear grade and size of the tumour is 
shown in table 8. It can be seen that the mean size increases with grade.
Younger patients and those with smaller tumours tended to have lower 
grade  tumours  when  compared  with  older  patients  and  those  with  larger 
tumours. This association is corroborated by many other studies.
The papillary RCC tumours were assigned grade according to whether 
they were type I or type II tumors. 62.5% were (basophilic) type I and were 
classified as low grade. The remaining 37.5% were (eosinophilic) type II and 
were classified as high grade. There was typically sharp circumscription of the 
tumour from the normal tissue. All cases had tubulopapillary architecture and 
two of them also had cystic areas. Necrosis, foamy histiocytes in the papillary 
cores and inflammatory cells were seen in varying proportions.
Most of the chromophobe RCC had cells with irregular raisinoid nuclei 
with features of grade II. Some of them had prominent nuclei at low power 
examination and with features of grade III. However nuclear grading has not 
been recommended in chromophobe RCC.
Five cases (10.42%) of clear cell  RCC had sarcomatoid areas.  These 
areas showed fibrosarcomatous (fascicles and herring bone), malignant fibrous 
histocytoma – like (storiform) and undifferentiated patterns. One of our cases 
had  >  95% area  composed of  sarcomatous  elements  and  only  a  focal  area 
showed clear cells and eosinophilic cells leading to a diagnosis of clear cell 
RCC. Another case showed rhabdomyoblast like differentiation in the form of 
large  cells  with  abundant  bright  eosinophilic  cytoplasm.  There  was  no 
sarcomatoid differentiation in other subtypes of RCC. 
Holger Moch et al and John C. Cheville et al have reported sarcomatoid 
differentiation in 8% and 5.2% of clear cell RCC respectively.
Irrespective of the proportion of sarcomatoid elements in the tumour, 
these cases portend a worse prognosis29,30.  Many tumours have conclusively 
proven  that  when  matched  for  stage,  necrosis,  studies  size,  patients  with 
sarcomatoid  differentiation  have  significantly  worse  prognosis  than  those 
without  it.  Hence  the  presence  of  sarcomatoid  area  is  accepted  as  an 
independent histologic prognostic parameter.
Analyzing for correlation of nuclear grade with the amount of histologic 
necrosis, 81.25% of low grade tumours had necrosis < 25% and 18.75% had 
necrosis 25 – 50%. In comparison, only 22.22% of high grade tumours had 
necrosis  <  25%,  51.85% had  necrosis  25  –  50%  and  25.93%  had  >50% 
necrosis. Thus increasing nuclear grade positively correlated with the amount 
of histologic necrosis.
In the chi square test analysis, this difference was found to be highly 
significant (χ2 = 16.10, D.F. = 2 and P < 0.001).
Some  authors  have  found  that  histologic  tumour  necrosis  was 
significantly associated with death from clear cell RCC and chromophobe RCC 
but not papillary RCC.
Invasion of the renal capsule and renal sinus veins upstages the tumour 
and were  analysed in  all  cases  18.61% of clear  cell  RCC showed capsular 
invasion  only,  27.91%  of  clear  cell  RCC  showed  vascular  invasion  only, 
whereas 41.86% clear cell RCC showed both capsular and vascular invasion 
and 11.62% did not have either.
These parameters  were also analysed gradewise in the Fuhrmans and 
two  tier  system.  From  these  data,  it  was  noted  that  there  was  a  definite 
propensity for invasion with increasing grade.
All  high  grade  tumours  showed either  capsular  or  vascular  invasion, 
with 66.67% of them showing both. In the low grade tumours, 68.75% shoed 
either  capsular  or  vascular  invasion  and  the  remainder  did  not  show  any 
invasion.
The significance level of the difference between proportion of low and 
high  grade  tumours  showing  capsular  invasion  was  calculated  using  Chi  – 
square test. χ2 = 9.11 and P < 0.005. This showed that the difference was highly 
significant and not attributable to chance alone.
The same test was carried out for vascular invasion data and the χ2 value 
was 12.56, P < 0.001 which again was highly significant.
The renal sinus and the veins in it are easily invaded owing to the lack 
of a connective tissue capsule between them and the tumour. So sinus invasion 
occur earlier than capsular invasion in many cases.
In  our  study,  more  tumours  showed evidence  of  sinus  vein  invasion 
(n=30) than capsular invasion (n=26). This is in line with the above mentioned 
argument regarding invasion.
Some authors believe that grade III and grade IV tumors do not have 
sufficient  difference in patients  outcome to  justify  their  separation into two 
categories. They advocate using only two grades instead of four. We analysed 
grade  III  and  IV tumours  for  differences  in  prognostic  parameters  such  as 
histologic tumour necrosis, capsular and vascular invasion using χ2 test. 
When relation with necrosis was tested, a χ2 value of 2 with two degree 
of  freedom  and  P  >  0.1  was  obtained,  which  showed  that  there  was  no 
significant difference.
For association with capsular invasion, a χ2 value of 0.01 and P > 0.5 
was obtained. Similarly, vascular invasion data yielded χ2 value of 0.46 and P > 
0.4 which also discounted any significant difference among grade III and grade 
IV tumours.
Among the  eight  cases  of  papillary  RCC in  our  series,  two  showed 
invasion of the capsule but none of them had vascular invasion.
All the chromophobe RCC were well circumscribed lesions and none of 
them showed  evidence of invasion either grossly or microscopically. Out of 
the  7  cases,  5  had  typical  morphology  and  2  were  eosinophilic  variants. 
Chromophobe RCC, especially the eosinophilic  variant can be distinguished 
from oncocytoma by the use of Hale’s colloidal iron stain. Strong diffuse and 
reticular  positivity  in  cytoplasm  was  seen  conforming  to  the  diagnosis  of 
chromophobe RCC. The microvesicles, which are the cause for this appearance 
on Hale’s stain, are an integral and unique morphologic feature of this tumour. 
Electron microsopy can also be of use in demonstrating these microvesicles.
The exact  nature  of  these  microvesicles  is  not  known.  Some authors 
propose a mitochondrial origin but there is no direct evidence to that effect. 
Bonsib  and  Lager,  in  a  study  of  5  chromophobe  RCC,  encountered  a  rare 
transitional form in which budding of a vesicle appeared to occur from the 
outer  mitochondrial  membrane.  They  did  not  endorse  the  concept  of  a 
mitochondrial origin because of the rarity of such findings.
There were 12 cases of TCC in our study with a male – female ratio of 
5 : 1. The peak incidence was seen in the seventh decade, but unlike RCC, a 
number of cases occurred in the younger age group also. All the tumours were 
centred at the renal pelvis. Three cases exhibited multifocality and six cases 
showed ureteric invasion. All of them had invaded the renal parenchyma as 
well. In general, TCC had more friable and necrotic areas than did RCC. When 
the grading system of bladder TCC was applied to these cases, all of them were 
seen to have grade III features.
In the benign tumours category, we had 3 cases of angiomyolipoma and 
1  case  of  hemangioma.  All  of  them had pre  operatively  been  classified  as 
malignant tumours on the basis of clinical and radiological data. Even the gross 
features gave an impression of renal cell carcinoma and only histopathological 
examination revealed the true nature of these lesions.
 
Fig.1, 
Clear cell 
RCC – 
External 
appearance 
Fig.2, Clear Cell RCC  
External appearance after stripping the capsule  
 Fig.3, Clear cell RCC showing solid and cystic areas. 
Normal kidney at upper and lower poles  
 
Fig.4, Large cystic and solid areas in clear cell RCC
 Fig.5, Clear Cell RCC – Cut Surface
Fig.6, Clear Cell RCC – Cut Surface
Normal kidney at lower pole only
 Fig.7, Chromophobe RCC 
Brown coloured mass occupying almost entire kidney
 
Fig.8, Papillary RCC 
The tumour extensively replaced the kidney parenchyma 
Fig.9, Clear cell RCC – Fuhrman’s nuclear grade I (Low Power)
Fig.10, Clear cell RCC – Fuhrman’s nuclear grade II (Low Power)
Fig.11, Clear cell RCC – Fuhrman’s nuclear grade III (Low Power)
Arborising vasculature is also evident 
Fig.12, Clear cell RCC – Fuhrman’s nuclear grade IV (Low Power)
Few mitotic figures seen 
Fig.13, The cells of clear cell RCC – polygonal shaped with 
well defined cell borders (High Power) 
Fig.14, Clear cell RCC with focus of calcification (Low Power)
Fig.15, 16   Mesh thrombus in a sinus vein (Scanner View)
Fig.17, Tumour thrombus in clear cell RCC (Low Power)
Fig.18, Sarcomatoid pattern in clear cell RCC (low power)
Fig.19, Rhabdomyoblast – like differentiation in sarcomatoid area 
(High Power) 
Fig.20, Encapsulation and sharp circumscription in papillary RCC 
(Low Power)
Fig.21, Tubulopapillary Areas in Type 1 Papillary RCC (Low Power)
Fig.22, Type II Papillary RCC – Eosinophilic Cells (Low Power)
Fig.23, Papillary cores distended with foamy histiocytes (Low Power)
Fig.24, Chromophobe RCC 
Typical Cells with Perinuclear Halo (Low Power)  
Fig.25, Chromophobe RCC – Eosinophilic cells (High Power)
Fig.26, Chromophobe RCC Hale’s Colloidal Iron Stain 
Diffuse and Reticular Positivity (High Power)
Fig.27, TCC with large areas of necrosis (Low Power)
Fig.28, Angiomyolipoma 
Admixture of Fat, Smooth muscle, Blood Vessel (Low Power)     
SUMMARY AND CONCLUSION
1. The incidence of RCC appears to be on the rise in our study population.
2. The age of the patient and size of the tumour show good correlation with 
histological grade.
3. Renal sinus invasion appears to precede the capsular invasion.
4. The amount of histologic tumour necrosis shows significant association 
with other prognostic parameters.
Our knowledge of the biology of renal tumors has come a long way from 
the time when they were classified based on gross morphology alone to the 
present  day  when  a  combined  multimodal  approach  using  conventional 
histology,  special  histochemical  stains,  immunohistology,  molecular 
biology and cytogenetics is used to classify these tumors. Nevertheless, the 
time – tested. Hematoxylin and Eosin section is still sufficient to diagnose a 
majority of the lesions and the information gained from these sections have 
overriding mandate over the data obtained from other ancillary techniques.
In our study, we had attempted to define the histomorphological profile of 
adult renal tumors among patients treated at our Institution. The results in 
general were comparable to those reported from other large series studies. 
The  important  histologic  prognostic  parameters  were  nuclear  grade, 
presence  of  sarcomatoid  component,  amount  of  necrosis  and  should  be 
consistently  documented  in  all  cases  of  RCC  to  stratify  patients  by 
prognosis. These prognostic parameters differed by histological subtype. A 
significant proportion of RCC, apparently renal – limited, had entered renal 
sinus  fat  and  sinus  veins  which  could  indicate  an  important  portal  for 
metastasis. Hence handling of renal carcinoma specimens in the gross room 
must also focus on the renal sinus. The grading of RCC as low and high 
grades, resulted in the division of tumours into two well defined categories 
which  had  significant  differences  in  their  association  with  known 
prognostic parameters.
The  study  of  various  pathological  features  of  renal  tumours  and  their 
patterns of invasion helps in unraveling the natural history of these lesions. 
Without this knowledge of tumour behaviour, it would be difficult to decide 
on  conservative  treatment  options  for  small  renal  –  limited  tumours. 
Prospective studies with adequate patient follow up data are required for 
this purpose. The importance of subtyping may further increase as advanced 
treatment modalities like tumor vaccines,immunotherapy and gene therapy31 
come  into  routine  oncologic  practice  and  management  becomes 
individualised to each patient.              
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MASTER CHART
S. NO. HPE NO AGE SEX LATERALITY PROCEDURE DIAGNOSIS GRADE
1. 219/ 03 75yrs M Left Radical nephrectomy TCC III
2. 567/ 03 40 yrs M Right Radical nephrectomy Clear Cell RCC II
3. 893/ 03 50 yrs M Right Radical nephrectomy Clear Cell RCC IV
4. 1557/ 03 48 yrs F Left Consultation slide Clear Cell RCC IV
5. 1828/ 03 65 yrs M Right Imaging guided Biopsy Clear Cell RCC Not graded
6. 2086/ 03 62 yrs M Right Radical nephrectomy Clear Cell RCC I
7. 2877/ 03 60 yrs M Left Radical nephrectomy Clear Cell RCC III
8. 3018/ 03 56 yrs M Right Radical nephrectomy Clear Cell RCC II
9. 3286/ 03 58 yrs M Left Radical nephrectomy Clear Cell RCC III
10. 3743/ 03 22 yrs F Left Radical nephrectomy Clear Cell RCC II
11. 4025/ 03 52yrs F Left Radical nephrectomy Clear Cell RCC II
12. 4525/ 03 60 yrs F Left Imaging guided Biopsy Clear Cell RCC Not graded
13. 4571/ 03 60 yrs M Left Radical nephrectomy TCC II
14. 4676/ 03 55 yrs M Left Imaging  guided Biopsy Clear Cell RCC Not graded
15. 4885/ 03 65 yrs F Left Radical nephrectomy TCC III
16. 5271/ 03 60 yrs M Right Consultation slide Clear Cell RCC Not graded
17. 5315/ 03 50 yrs M Right Radical nephrectomy TCC  III
18. 5468/ 03 50 yrs F Right Radical nephrectomy Angiomyolipoma -
19. 5773/ 03 30 yrs F Right Radical nephrectomy Chromophobe RCC Not Graded
S. NO. HPE NO AGE SEX LATERALITY PROCEDURE DIAGNOSIS GRADE
20. 5927/ 03 53 yrs M Left Radical nephrectomy Clear Cell RCC  IV
21. 6125/ 03 51 yrs M Right Radical nephrectomy Clear Cell RCC IV
22. 19/ 04 65 yrs M Right Radical nephrectomy TCC III
23. 782/ 04 40 yrs M Right Radical nephrectomy Clear Cell RCC IV
24. 885/ 04 50 yrs M Right Radical nephrectomy TCC III
25. 975/ 04 47 yrs M Right Radical nephrectomy TCC III
26. 1282/ 04 44 yrs F Left Radical nephrectomy Chromophobe RCC Not Graded
27. 2169/ 04 50 yrs F Left Radical nephrectomy Clear Cell RCC II
28. 2264/ 04 55 yrs M Left Radical nephrectomy Clear Cell RCC II
29. 2501/ 04 68 yrs M Right Radical nephrectomy Clear Cell RCC III
30. 2576/ 04 73 yrs M Left Radical nephrectomy Clear Cell RCC IV
31. 3163/ 04 30 yrs M Left Radical nephrectomy Clear Cell RCC III
32. 3376/ 04 60 yrs M Right Imaging  guided Biopsy Clear Cell RCC Not Graded
33. 3695/ 04 56 yrs M Left Radical nephrectomy Clear Cell RCC III
34. 4098/ 04 60 yrs M Right Radical nephrectomy Papillary RCC type 2 High grade
35. 4418/ 04 55 yrs M Right Radical nephrectomy Clear Cell RCC IV
36. 5306/ 04 75 yrs M Right Radical nephrectomy Clear Cell RCC III
37. 5391/ 04 32 yrs M Left Imaging  guided Biopsy TCC III
38. 6130/ 04 65 yrs F Left Radical nephrectomy Clear Cell RCC II
39. 6269/ 04 80 yrs M Right Radical nephrectomy Clear Cell RCC II
40. 6484/ 04 60 yrs M Left Imaging  guided Biopsy Clear Cell RCC Not Graded
S. NO. HPE NO AGE SEX LATERALITY PROCEDURE DIAGNOSIS GRADE
41. 6878/ 04 73 yrs M Left Radical nephrectomy Clear Cell RCC IV
42. 7073/ 04 35 yrs M Left Radical nephrectomy TCC III
43. 7214/ 04 57 yrs M Left Radical nephrectomy Clear Cell RCC III
44. 7275/ 04 55 yrs F Left Radical nephrectomy Clear Cell RCC III
45. 7449/ 04 58 yrs M Right Radical nephrectomy Clear Cell RCC IV
46. 7492/ 04 62 yrs M Left Radical nephrectomy Clear Cell RCC III
47. 139/ 05 55 yrs M Left Radical nephrectomy Clear Cell RCC IV
48. 254/ 05 60 yrs M Left Radical nephrectomy Clear Cell RCC III
49. 494/ 05 48 yrs F Right Radical nephrectomy Papillary RCC type 1 I
50. 805/ 05 70 yrs M Left Radical nephrectomy Papillary RCC type 2 II
51. 808/ 05 48 yrs M Right Radical nephrectomy Angiomyolipoma -
52. 1224/ 05 38 yrs M Right Radical nephrectomy Chromophobe RCC Not graded
53. 1674/05 64 yrs M Left Radical nephrectomy TCC III
54. 2320/ 05 39 yrs M Left Radical nephrectomy Papillary RCC type 2 II
55. 3017/ 05 45 yrs M Left Radical nephrectomy Clear Cell RCC III
56. 3388/ 05 45 yrs M Right Radical nephrectomy Clear Cell RCC IV
57. 4332/ 05 60 yrs F Right Radical nephrectomy TCC III
58. 4357/ 05 55 yrs M Right Radical nephrectomy Clear Cell RCC IV
59. 4358/ 05 65 yrs M Right Radical nephrectomy Clear Cell RCC IV
60. 4508/ 05 24 yrs F Right Radical nephrectomy Clear Cell RCC III
61. 4701/ 05 33 yrs M Right Radical nephrectomy TCC III
S. NO. HPE NO AGE SEX LATERALITY PROCEDURE DIAGNOSIS GRADE
62. 5490/ 05 60 yrs F Left Radical nephrectomy Clear Cell RCC II
63. 6228/ 05 22 yrs F Left Radical nephrectomy Angiomyolipoma -
64. 6464/ 05 32 yrs M Left Radical nephrectomy Clear Cell RCC II
65. 6493/ 05 65 yrs M Left Imaging guided biopsy Papillary RCC type 1 I
66. 16/ 06 66 yrs M Left Radical nephrectomy Clear Cell RCC II
67. 68/ 06 45 yrs F Left Radical nephrectomy Clear Cell RCC II
68. 468/ 06 62 yrs F Right Radical nephrectomy Clear Cell RCC II
69. 562/ 06 47 yrs M Left Radical nephrectomy Chromophobe RCC Not graded
70. 906/ 06 45 yrs F Left Radical nephrectomy Chromophobe RCC Not graded
71. 919/ 06 35 yrs F Right Radical nephrectomy Papillary RCC type 1 I
72. 1445/ 06 45 yrs F Right Radical nephrectomy Hemangisma -
73. 2107/ 06 65 yrs M Right Radical nephrectomy Clear Cell RCC III
74. 2443/ 06 50 yrs F Right Radical nephrectomy Papillary RCC type 1 I
75. 2745/ 06 50 yrs M Left Radical nephrectomy Clear Cell RCC II
76. 3115/ 06 65 yrs M Right Radical nephrectomy Clear Cell RCC II
77. 3320/ 06 61 yrs M Left Radical nephrectomy Clear Cell RCC III
78. 3748/ 06 50 yrs M Left Radical nephrectomy Chromophobe RCC Not graded
79. 3835/ 06 50 yrs M Right Radical nephrectomy Papillary RCC type 1 I
